The Era of AI Healthcare: The Growing Need for Regulatory Reform in Korean Medicine
Recently, the WHO Regional Office for Europe and the Portuguese government jointly hosted an 'AI Healthcare' conference. The meeting featured in-depth discussions on the development of AI-driven disease diagnosis, treatment, and personalized medicine.
Experts emphasized that while AI technology is being rapidly adopted in medical settings, there is an urgent need for data management systems and regulations to support it. In particular, the establishment of 'data governance' that can safely utilize medical data while protecting patient privacy was treated as a key agenda item at the conference.
This conference offers important implications for the Korean medical community. It is pointed out that despite possessing excellent medical technology, Korea's introduction of innovative AI-based medical services is somewhat delayed due to complex regulations.
Moving forward, the Korean government and the medical community must secure the competitiveness of the AI healthcare industry by improving regulations to meet global standards. It is a critical time to develop flexible policies that prioritize patient safety while encouraging technological innovation.